Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time, the S 500 had slid by 0.9% and the Nasdaq Composite was down 1.4%.

Illumina, a biotech company that develops and manufactures genetic testing systems, reported disappointing fourth-quarter numbers after the closing bell Thursday.

Illumina's revenue has stagnated or declined for several years now, and its total sales for 2024 were $4.3 billion, down from 2023's $4.5 billion. However, its bottom line was positive for the second quarter in a row in Q4, and its earnings of $0.95 per share beat expectations of $0.91 per share.

Continue reading

Source Fool.com